Approved Use

Repatha® is an injectable prescription medicine used:

  • in adults with cardiovascular disease to reduce the risk of heart attack, stroke, and certain types of heart surgery. READ MORE
  • along with diet alone or together with other cholesterol-lowering medicines in adults with high blood cholesterol levels called primary hyperlipidemia (including a type of high cholesterol called heterozygous familial hypercholesterolemia [HeFH]) to reduce low-density lipoprotein (LDL) or bad cholesterol.

You are now leaving Repatha.com

This information is intended only for U.S. healthcare professionals. If you are a healthcare professional, click “I Agree” to continue.

I Agree

Take me back

Get Started With RepathaReady®

Whether you're already taking Repatha® or considering asking your doctor about a prescription, RepathaReady® offers helpful resources to support you on your path to lowering high bad cholesterol.

Sign up today to:

  • See if you are eligible for the Repatha® Copay Card*
  • Sign up for courtesy medication reminders and
    informational emails
  • Learn more about financial information resources
  • Receive more information about Repatha® and
    how to talk to your doctor

*For commercially insured patients. Programs maximums apply.

Do you already have a Repatha® prescription?


In addition to educational emails, RepathaReady® offers support services to help you get on track and stay there.

Select additional services


I would like to receive reminders via

Important Program Information: This program is intended for the limited purpose of delivering courtesy reminder notifications to remind you to schedule your next injection of Repatha® or to pick up your refill. However, it is up to you and/or your caregiver to ensure you obtain your next injection in a timely manner and in accordance with your doctor’s instruction. This program is not intended to be a source of medical advice or treatment and does not replace in any way independent medical advice regarding your diagnosis or treatment. Any questions about medications or health care should be presented to your doctor.

As a reminder, you must be 18 years old to participate. By participating, you agree that you are solely responsible for determining whether the use of this program is right for you, and you agree to release Amgen from any liability relating to your use of this program.



REPATHA® REGISTRATION

GET STARTED WITH
REPATHAREADY®

REPATHA® COURTESY REMINDERS

AMGEN’S PATIENT
AUTHORIZATION

REPATHAREADY® REGISTRATION

GOOD NEWS: YOU’RE ENROLLED!
USE YOUR REPATHA® COPAY CARD TODAY
TO PAY AS LITTLE AS $5 PER MONTH*

1 2 3 4




Let us know if either of the following applies to you so we can personalize the information you receive from us:

Before starting Repatha®, have you ever had a heart attack?

Before starting Repatha®, did you struggle to lower your bad cholesterol?



1 2 3 4


Uses and Disclosure of Personal Information

I authorize Amgen and its contractors and business partners (“Amgen”) to use and/or disclose my personal information, including my personal health information, for the following purposes only:

To operate, administer, enroll me in, and/or continue my participation in Amgen’s Repatha® information program and related activities; to provide me with informational and promotional materials relating to Amgen products and services and/or my condition or treatment; and/or to improve, develop, and evaluate products, services, materials, and programs related to my condition or treatment.

I understand that the operation and administration of certain services and/or programs may require that Amgen contact me by mail and/or email. I understand and consent to Amgen contacting me using the contact information provided in this form to enroll me in, operate, and administer the Repatha® information program.

further understand that the Repatha® information program and additional informational and marketing communications related to my condition and treatment are optional and free services. I do not have to sign this authorization, and this authorization in no way affects my right to obtain any medications. To obtain a copy of this authorization or to cancel at any time, I can contact Amgen by calling 1-844-REPATHA (1-844-737-2842) or by writing to Amgen, PO Box 781046, Indianapolis, IN 46278-8046. The Amgen Privacy Statement can be found at http://www.amgen.com/privacystatement.

By checking the “I Agree” box, I am electronically indicating that I have read and understood Amgen’s Patient Authorization (above in its full text), that I am legally authorized to consent, and that I am providing my consent as the patient or the patient’s legal guardian for Amgen and its contractors and business partners to use and share the personal information I provide for the purposes described within the Patient Authorization. By exiting the page, my activation and enrollment into RepathaReady® will be discontinued.


OPTIONAL: Amgen may contact me using the contact information provided in this form for participation in market research activities associated with Amgen’s products, services, and/or my condition or treatment.





1 2 3 4


Please answer the questions below to see if you are eligible for the Repatha® Copay Card.

Which type of insurance do you use to pay for your Repatha® prescription?


Health insurance for you or a family member purchased and/or received through an employer, healthcare exchange, or commercial plan through the Federal Employee Health Benefits (FEHB) program
Commercial insurance (e.g., self-purchased or through an employer)
Includes Medicare Part D, Medicare, TRICARE®, Department of Defense, or Veterans Affairs programs
Government-provided (e.g., Medicare Part D, Medicaid)
I don’t have insurance
I don’t know

Are you eligible for Medicare but receiving prescription drug coverage from a former employer, union, or welfare plan?





1 2 3 4

Would you like to receive courtesy injection reminders?

How often do you take Repatha®?


When would you like your first dose reminder?

Would you like to receive prescription refill reminders?


When would you like your first refill reminder?

How often would you like to receive prescription refill reminders?





1 2 3 4


To use your Copay Card, take these

3 simple steps

Print your Copay Card

Share your Copay Card information with your pharmacist

Pick up your Repatha® prescription

You will receive an email with your Repatha® Copay Card. Be sure to bring the email or a copy of this page with you to the pharmacy. Don’t see it in your inbox? Check your spam folder. If you have any questions, please contact 1-844-REPATHA (1-844-737-2842).

If you have questions about your Repatha® Copay Card, please call 1-844-REPATHA.

*Up to an annual maximum. Terms and conditions apply.


Print

You will receive an email with your Repatha® Copay Card. Be sure to bring the email or a copy of this page with you to the pharmacy. Don’t see it in your inbox? Check your spam folder. If you have any questions, please contact 1-844-REPATHA(1-844-737-2842)

If you have questions about your Repatha® Copay Card, please call 1-844-REPATHA.

*Up to an annual maximum. Terms and conditions apply.

RepathaReady® Mobile Messaging Program Terms & Conditions

NOTICE: The RepathaReady® mobile Short Message Service (SMS) program for Repatha® (evolocumab) is not intended to be a source of medical advice or care. Please contact your healthcare provider if you have any questions about your medical condition, diagnosis, treatment, or care.

Amgen’s RepathaReady® Reminders mobile SMS program runs on the short code 95093. Amgen will not charge you to use this Service; however, your Wireless Service Provider may charge for sending and/or receiving messages and for airtime. Message and Data Rates May Apply.

  1. By opting into the RepathaReady® program you consent to receive a maximum of 6 messages per month from mobile short code 95093.

  2. To enroll in RepathaReady® Reminders or receive subscription messages: Visit Repatha.com or call 1-844-737-2842. Provide the required information including your mobile phone number. You will receive a mobile opt-in request message from 95093. Follow the texting prompts to JOIN.

  3. Text HELP to 95093 for help, STOP to 95093 to cancel.

This Service is available on the following carriers: AT&T, Verizon Wireless, Sprint, Virgin Mobile, Boost, T-Mobile, MetroPCS, U.S. Cellular, Cricket Wireless, Google Voice, nTelos, Alaska Communications Systems (ACS), bandwidth.com (includes Republic Wireless), Bluegrass Cellular, Boost-CDMA, C Spire Wireless (Cellular South), CableVision, Carolina West Wireless, CellCom, Cellular One of N.E. Arizona, Chariton Valley Cellular, Chat Mobility, Cleartalk (Flat Wireless), Copper Valley Telecom, DTC Wireless, Duet Wireless, East Kentucky Network (Appalachian Wireless), ECIT/Cellular One of East Central Illinois, GCI Communications, Illinois Valley Cellular, Inland Cellular, IWireless, Leaco Rural Telephone Cooperative, Limitless Mobile, Mid-Rivers Communications, Mobi PCS, MobileNation/SI Wireless, MTA Wireless/Matanuska Kenai, MTPCS Cellular One (Cellone Nation), Nemont US UMTS, Nex Tech Communications, Northwest Missouri Cellular, Panhandle Wireless, Pine Cellular, Pioneer Cellular, Plateau Wireless, Rural Independent Network Alliance (RINA), Sagebrush, SouthernLINC, SRT Communications, Thumb Cellular, TracFone, Union Telephone, United Wireless, Viaero Wireless, and West Central Wireless. T-Mobile is not liable for delayed or undelivered messages.

For additional questions, please call 1-844-737-2842.

Amgen Inc. (“Amgen”) reserves the right, in its sole discretion, to change, modify, add, or remove these Mobile Terms of Use (“Mobile Terms”) at any time. Amgen may in its discretion change or suspend the Service (defined below) at any time. If you are dissatisfied with the Service or the content received through the Service, your sole remedy is to discontinue use of the Service.

By using the Service and accepting these terms, you also agree to Amgen’s standard Terms of Use, incorporated herein by reference. In the event of a conflict between the standard Terms of Use and these Mobile Terms, these Mobile Terms shall prevail. For Amgen privacy practices, please see our Privacy Policy. For the full Mobile Terms and Conditions related to this SMS program, please see our Mobile Terms and Conditions page.

Did you agree to the mobile terms and conditions to receive text messages?

If not, go back to agree, or continue to
complete the form. If you do not agree,
you will not receive information related to
Repatha® via mobile phone text messages.

Go Back Continue

Your registration is complete.

You will now begin receiving email and/or text updates from Repatha®.

Return to Homepage

Your registration is complete.

You will now begin receiving reminders from Repatha®.

Return to Homepage

Based on the information you provided, it appears that you are not eligible for the Repatha® Copay Card.

However, there may be other ways to lower your out-of-pocket costs. Call RepathaReady® at 1-844-REPATHA (1-844-737-2842) to discuss your options.

Contact Us

We just need a little more information from you.

Call RepathaReady® at 1-844-REPATHA (1-844-737-2842) to see if you qualify for the Repatha® Copay Card.

Contact Us

There was an error processing your request.

Please call us at 1-844-REPATHA (1-844-737-2842) to complete your request.

Contact Us

REPATHA COPAY CARD FULL TERMS & CONDITIONS

Summary of Terms and Conditions

It is important that every patient read and understand the full Repatha® (evolocumab) Copay Card Terms and Conditions. The following summary is not a substitute for reviewing the Terms and Conditions in their entirety.

As further described in the full terms and conditions, in general:

  • The Repatha® Copay Card is open to patients with commercial insurance, regardless of financial need. The program is not valid for patients whose Repatha® prescription is paid for in whole or in part by Medicare, Medicaid, or any other federal or state programs. It is not valid for cash-paying patients or where prohibited by law.
  • With the Repatha® Copay Card, a commercially insured patient who meets eligibility criteria may pay as little as a $5 copay per month for their Repatha® monthly out-of-pocket costs. Monthly out-of-pocket costs include co-payment, co-insurance, and deductible out-of-pocket costs. Amgen will pay the remaining eligible out-of-pocket costs on behalf of the patient up to a Maximum Monthly Benefit, a Maximum Annual Program Benefit and/or the Patient Total Program Benefit. Patients are responsible for all amounts that exceed these limits.
  • The program provides assistance up to a Maximum Monthly Benefit except that the Maximum Monthly Benefit will not apply to the first three (3) fills of the Repatha® Copay Card for Repatha® in any given calendar year.
  • Offer is subject to change or discontinuation without notice.
  • The Repatha® Copay Card provides support up to the Maximum Monthly Benefit, the Maximum Annual Program Benefit and/or Patient Total Program Benefit. If a patient’s commercial insurance plan imposes different or additional requirements on patients who receive Repatha® Copay Card benefits, Amgen has the right to reduce or eliminate those benefits. Whether you are eligible to receive the Maximum Monthly Benefit, Maximum Program Benefit or Patient Total Program Benefit is determined by the type of plan coverage you have. Please ask your RepathaReady® counselor to help you understand eligibility for the Repatha® Copay Card, and whether your particular insurance coverage is likely to result in your reaching the Maximum Monthly Benefit, the Maximum Annual Program Benefit, or your Patient Total Program Benefit , by calling 1-844-REPATHA (1-844-737-2842).
  • Please see the full terms and conditions at Repatha.com/#copaycard.

    Repatha® Copay Card Full Terms & Conditions
  1. ELIGIBILITY
  2. Eligibility Criteria: Subject to program limitations and terms and conditions, the Repatha® Copay Card is open to patients who have a Repatha® prescription and who have commercial or private insurance, including plans available through state and federal healthcare exchanges. This program helps eligible patients cover out-of-pocket costs related to Repatha®, up to program limits. There is no income requirement to participate in this program.

    This offer is not valid for patients whose Repatha® prescription is paid for in whole or in part by Medicare, Medicaid, or any other federal or state programs. It is not valid for cash-paying patients or where prohibited by law. A patient is considered cash-paying where the patient has no insurance coverage for Repatha® or where the patient has commercial or private insurance but Amgen in its sole discretion determines the patient is effectively uninsured because such coverage does not provide a material level of financial assistance for the cost of a Repatha® prescription. This offer is only valid in the United States, Puerto Rico, and the US territories.

  3. PROGRAM BENEFITS
  4. The Repatha® Copay Card helps provide out-of-pocket support to eligible patients for their Repatha® prescription up to program limits. See PROGRAM DETAILS for full description.

    The Repatha® Copay Card offer does not cover out-of-pocket costs for any patient whose selected coverage option under their commercial insurance plan does not apply Repatha® Copay Card payments to satisfy the patient’s co-payment, deductible, or co-insurance for Repatha®. Patients with these plan limitations are not eligible for the Repatha® Copay Cardbut may be eligible for other needs-based assistance provided by Amgen. These programs are often referred to as accumulator adjustment programs. If you believe your commercial insurance plan may have such limitations, please contact RepathaReady® at 1-844-REPATHA (1-844-737-2842).

    The Repatha® Copay Card also may provide a reduced benefit amount, unilaterally determined by Amgen in its sole discretion, to satisfy the out-of-pocket cost-sharing requirement for any patient whose plan or plan agent (including, but not limited to, a Pharmacy Benefit Manager (PBM)) requires enrollment in the Repatha® Copay Card as a condition of the plan or PBM waiving some or all of an otherwise applicable patient out-of-pocket cost-sharing amount. These programs are often referred to as copay maximizer programs. If you believe your commercial insurance plan may have such limitations, please contact RepathaReady® at 1-844-REPATHA (1-844-737-2842). Health plans, specialty pharmacies, and Pharmacy Benefit Managers (individually and collectively “Plan Administrators”) are prohibited from enrolling patients in the Repatha® Copay Card. Plan Administrators are prohibited from assisting patients with enrollment in the Repatha® Copay Card. The patient, or his/her legal representative, must personally enroll in the Repatha® Copay Cardin order to be eligible for program benefits.

    If at any time a patient begins receiving prescription drug coverage under any state or government program (including but not limited to Medicare, Medicaid, TRICARE, Department of Defense, or Veteran Affairs programs), the patient will no longer be able to use this card and they must contact RepathaReady® at 1-844-REPATHA (1-844-737-2842) (Monday through Sunday, from 9am to 11pm ET) to stop their participation in this program.

    Patients may not seek reimbursement for the value received from the Repatha® Copay Card from any third-party payers, including a flexible spending account or healthcare savings account. Participating in this program means that you are ensuring you comply with any required disclosure regarding your participation in the Repatha® Copay Card of your insurance carrier or Pharmacy Benefit Manager. Restrictions may apply. Offer is subject to change or discontinuation without notice. This is not health insurance.

  5. PROGRAM DETAILS
  6. With the Repatha® Copay Card, a commercially insured patient who meets eligibility criteria may pay as little as a $5 copay per month for their Repatha® monthly out-of-pocket costs.

    • For all eligible patients, the Repatha® Copay Card offers:
      • A program benefit that covers the patient’s eligible out-of-pocket prescription costs for Repatha® (copay, deductible, or co-insurance) on behalf of the patient, up to a Maximum Monthly Benefit and/or a Maximum Annual Program Benefit.
      • Repatha® patients may pay $5 out of pocket at the first fill and at every refill, and Amgen will pay on behalf of the patient the remaining eligible out-of-pocket prescription costs (up to the Patient Total Program Benefit described below; Repatha® patients are responsible for all amounts that exceed this limit).
      • The Maximum Monthly Benefit will apply every month except that the first three (3) fills for Repatha® in each calendar year will not have a Maximum Monthly Benefit.
    • Maximum Monthly Benefit, Maximum Annual Program Benefit, and/or Patient Total Program Benefit and Benefits May Change, End, or Vary without notice.
    • The Maximum Annual Program Benefit must be applied to the Repatha® patient’s out-of-pocket costs (copay, deductible, or co-insurance).
    • The Patient Total Program Benefit amounts are unilaterally determined by Amgen in its sole discretion and will not exceed the Maximum Monthly Benefit or Maximum Annual Program Benefit. The Patient Total Program Benefit may be less than the Maximum Monthly Benefit or Maximum Annual Program Benefit, depending on the terms of a patient’s prescription drug plan, and may vary among individual patients covered by different plans, based on factors determined solely by Amgen, to ensure all programs funds are used for the benefit of the patient. Each patient is responsible for costs above the Patient Total Program Benefit amounts. Please ask your RepathaReady® representative to help you understand whether your particular insurance coverage is likely to result in your reaching the Maximum Monthly Benefit, Maximum Annual Program Benefit or your Patient Total Program Benefit amount by calling 1-844-REPATHA (1-844-737-2842) and follow the prompts.
    • Participating patients are solely responsible for updating Amgen with changes to their prescription health insurance including, but not limited to, initiation of insurance provided by the government, the addition of any coverage terms that do not apply Repatha® Copay Card benefits to reduce a patient’s out-of-pocket costs, such as accumulator adjustment benefit design or a copay maximization program. Participating patients are responsible for providing Amgen with accurate information necessary to determine program eligibility. By accepting payments from Amgen made on behalf of participating patients, participating PBMs and Plans likewise are responsible for providing Amgen with accurate information regarding patient eligibility.
    • Patients may use the card every time they fill their Repatha® prescription. Benefits reset each calendar year. Re-enrollment in the program is required at regular intervals. Patients may participate in the program as long as s/he re-enrolls as required by Amgen and s/he continues to meet all of the program’s eligibility requirements during participation in the program. Patients can enroll/re-enroll by calling 1-844-REPATHA (1-844-737-2842) or by going to Repatha.com/copaycard.

Try again soon.

It looks like you’re re-enrolling too soon. Your re-enrollment period begins 60 days prior to your expiration date.

If you have any questions or need further assistance, please call us at 1-844-REPATHA (1-844-737-2842).

Contact Us

We're currently processing your request.

Please do not press the back button or refresh the page until you have received a confirmation message.

Are you sure you don’t want reminders?

Select ‘Go Back’ below to choose what type of reminders you would like.

Go Back Exit to Homepage

REPATHA COPAY CARD FULL TERMS & CONDITIONS

SUMMARY OF TERMS AND CONDITIONS

It is important that every patient read and understand the full Repatha® (evolocumab) Copay Card Terms and Conditions. The following summary is not a substitute for reviewing the Terms and Conditions in their entirety.

As further described below, in general:

  • The Repatha® Copay Card is open to patients with commercial insurance, regardless of financial need. The program is not valid for patients whose Repatha® prescription is paid for in whole or in part by Medicare, Medicaid, or any other federal or state programs. It is not valid for cash-paying patients or where prohibited by law. (See ELIGIBILITY section below.)
  • With the Repatha® Copay Card, a commercially insured patient who meets eligibility criteria may pay as little as a $5 Copay per month for their Repatha® monthly out-of-pocket costs. Monthly out-of-pocket costs include copayment, co-insurance, and deductible out-of-pocket costs. Amgen will pay the remaining eligible out-of-pocket costs on behalf of the patient up to a Maximum Monthly Benefit, a Maximum Annual Program Benefit and/or the Patient Total Program Benefit. Patients are responsible for all amounts that exceed these limits. (See PROGRAM DETAILS section below.)
  • The program provides assistance up to a Maximum Monthly Benefit except that the Maximum Monthly Benefit will not apply to the first three (3) fills of the Repatha® Copay Card for Repatha® in any given calendar year.
  • Offer is subject to change or discontinuation without notice.
  • The Repatha® Copay Card provides support up to the Maximum Monthly Benefit, the Maximum Annual Program Benefit and/or Patient Total Program Benefit. If a patient’s commercial insurance plan imposes different or additional requirements on patients who receive Repatha® Copay Card benefits, Amgen has the right to reduce or eliminate those benefits. Whether you are eligible to receive the Maximum Monthly Benefit, Maximum Program Benefit or Patient Total Program Benefit is determined by the type of plan coverage you have. Please ask your RepathaReady® counselor to help you understand eligibility for the Repatha® Copay Card, and whether your particular insurance coverage is likely to result in your reaching the Maximum Monthly Benefit, the Maximum Annual Program Benefit, or your Patient Total Program Benefit , by calling 1-844-REPATHA (1-844-737-2842). (See PROGRAM BENEFITS section below.)

Repatha® Copay Card Full Terms & Conditions
  1. ELIGIBILITY
  2. Eligibility Criteria: Subject to program limitations and terms and conditions, the Repatha® Copay Card is open to patients who have a Repatha® prescription and who have commercial or private insurance, including plans available through state and federal healthcare exchanges. This program helps eligible patients cover out-of-pocket costs related to Repatha®, up to program limits. There is no income requirement to participate in this program.

    This offer is not valid for patients whose Repatha® prescription is paid for in whole or in part by Medicare, Medicaid, or any other federal or state programs. It is not valid for cash-paying patients or where prohibited by law. A patient is considered cash-paying where the patient has no insurance coverage for Repatha® or where the patient has commercial or private insurance but Amgen in its sole discretion determines the patient is effectively uninsured because such coverage does not provide a material level of financial assistance for the cost of a Repatha® prescription. This offer is only valid in the United States, Puerto Rico, and the US territories.

  3. PROGRAM BENEFITS
  4. The Repatha® Copay Card helps provide out-of-pocket support to eligible patients for their Repatha® prescription up to program limits. See PROGRAM DETAILS for full description.

    The Repatha® Copay Card offer does not cover out-of-pocket costs for any patient whose selected coverage option under their commercial insurance plan does not apply Repatha® Copay Card payments to satisfy the patient’s copayment, deductible, or co-insurance for Repatha®. Patients with these plan limitations are not eligible for the Repatha® Copay Card but may be eligible for other needs-based assistance provided by Amgen. These programs are often referred to as accumulator adjustment programs. If you believe your commercial insurance plan may have such limitations, please contact RepathaReady® at 1-844-REPATHA (1-844-737-2842).

    The Repatha® Copay Card also may provide a reduced benefit amount, unilaterally determined by Amgen in its sole discretion, to satisfy the out-of-pocket cost-sharing requirement for any patient whose plan or plan agent (including, but not limited to, a Pharmacy Benefit Manager (PBM)) requires enrollment in the Repatha® Copay Card as a condition of the plan or PBM waiving some or all of an otherwise applicable patient out-of-pocket cost-sharing amount. These programs are often referred to as copay maximizer programs. If you believe your commercial insurance plan may have such limitations, please contact RepathaReady® at 1-844-REPATHA (1-844-737-2842). Health plans, specialty pharmacies, and Pharmacy Benefit Managers (individually and collectively “Plan Administrators”) are prohibited from enrolling patients in the Repatha® Copay Card. Plan Administrators are prohibited from assisting patients with enrollment in the Repatha® Copay Card. The patient, or his/her legal representative, must personally enroll in the Repatha® Copay Card in order to be eligible for program benefits.

    If at any time a patient begins receiving prescription drug coverage under any state or government program (including but not limited to Medicare, Medicaid, TRICARE, Department of Defense, or Veteran Affairs programs), the patient will no longer be able to use this card and they must contact RepathaReady® at 1-844-REPATHA (1-844-737-2842) to stop their participation in this program.

    Patients may not seek reimbursement for the value received from the Repatha® Copay Card from any third-party payers, including a flexible spending account or healthcare savings account. Participating in this program means that you are ensuring you comply with any required disclosure regarding your participation in the Repatha® Copay Card of your insurance carrier or Pharmacy Benefit Manager. Restrictions may apply. Offer is subject to change or discontinuation without notice. This is not health insurance.

  5. PROGRAM DETAILS
  6. With the Repatha® Copay Card, a commercially insured patient who meets eligibility criteria may pay as little as a $5 Copay per month for their Repatha® monthly out-of-pocket costs.

    • For all eligible patients, the Repatha® Copay Card offers:
      • A program benefit that covers the patient’s eligible out-of-pocket prescription costs for Repatha® (copay, deductible, or co-insurance) on behalf of the patient, up to a Maximum Monthly Benefit and/or a Maximum Annual Program Benefit.
      • Repatha® patients may pay $5 out of pocket at the first fill and at every refill, and Amgen will pay on behalf of the patient the remaining eligible out-of-pocket prescription costs (up to the Patient Total Program Benefit described below; Repatha® patients are responsible for all amounts that exceed this limit).
      • The Maximum Monthly Benefit will apply every month except that the first three (3) fills for Repatha® in each calendar year will not have a Maximum Monthly Benefit.
    • Maximum Monthly Benefit, Maximum Annual Program Benefit, and/or Patient Total Program Benefit and Benefits May Change, End, or Vary without notice.
    • The Maximum Annual Program Benefit must be applied to the Repatha® patient’s out-of-pocket costs (copay, deductible, or co-insurance).
    • The Patient Total Program Benefit amounts are unilaterally determined by Amgen in its sole discretion and will not exceed the Maximum Monthly Benefit or Maximum Annual Program Benefit. The Patient Total Program Benefit may be less than the Maximum Monthly Benefit or Maximum Annual Program Benefit, depending on the terms of a patient’s prescription drug plan, and may vary among individual patients covered by different plans, based on factors determined solely by Amgen, to ensure all programs funds are used for the benefit of the patient. Each patient is responsible for costs above the Patient Total Program Benefit amounts. Please ask your RepathaReady® representative to help you understand whether your particular insurance coverage is likely to result in your reaching the Maximum Monthly Benefit, Maximum Annual Program Benefit or your Patient Total Program Benefit amount by calling 1-844-REPATHA (1-844-737-2842) and follow the prompts.
    • Participating patients are solely responsible for updating Amgen with changes to their prescription health insurance including, but not limited to, initiation of insurance provided by the government, the addition of any coverage terms that do not apply Repatha® Copay Card benefits to reduce a patient’s out-of-pocket costs, such as accumulator adjustment benefit design or a copay maximization program. Participating patients are responsible for providing Amgen with accurate information necessary to determine program eligibility. By accepting payments from Amgen made on behalf of participating patients, participating PBMs and Plans likewise are responsible for providing Amgen with accurate information regarding patient eligibility.
    • Patients may use the card every time they fill their Repatha® prescription. Benefits reset each calendar year. Re-enrollment in the program is required at regular intervals. Patients may participate in the program as long as s/he re-enrolls as required by Amgen and s/he continues to meet all of the program’s eligibility requirements during participation in the program. Patients can enroll/re-enroll by calling 1-844-REPATHA (1-844-737-2842) or by going to Repatha.com/copaycard.

Important Safety Information

Do not use Repatha® if you are allergic to evolocumab or to any of the ingredients in Repatha®.

Before you start using Repatha®, tell your healthcare provider about all your medical conditions, including if you are allergic to rubber or latex, are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed. The needle covers on the single-dose prefilled syringes and the inside of the needle caps on the single-dose prefilled SureClick® autoinjectors contain dry natural rubber. The single-dose Pushtronex® system (on-body infusor with prefilled cartridge) is not made with natural rubber latex.

Tell your healthcare provider or pharmacist about any prescription and over-the-counter medicines, vitamins, or herbal supplements you take.

What are the possible side effects of Repatha®?

Repatha® can cause serious side effects including, serious allergic reactions. Stop taking Repatha® and call your healthcare provider or seek emergency help right away if you have any of these symptoms: trouble breathing or swallowing, raised bumps (hives), rash or itching, swelling of the face, lips, tongue, throat or arms.

The most common side effects of Repatha® include: runny nose, sore throat, symptoms of the common cold, flu or flu-like symptoms, back pain, high blood sugar levels (diabetes), and redness, pain, or bruising at the injection site.

Tell your healthcare provider if you have any side effect that bothers you or that does not go away.

These are not all the possible side effects of Repatha®. Ask your healthcare provider or pharmacist for more information. Call your healthcare provider for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Please see full Prescribing Information.

Important Safety Information

Do not use Repatha® if you are allergic to evolocumab or to any of the ingredients in Repatha®.

Before you start using Repatha®, tell your healthcare provider about all your medical conditions, including if you are allergic to rubber or latex, are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed. The needle covers on the single-dose prefilled syringes and the inside of the needle caps on the single-dose prefilled SureClick® autoinjectors contain dry natural rubber. The single-dose Pushtronex® system (on-body infusor with prefilled cartridge) is not made with natural rubber latex.

Tell your healthcare provider or pharmacist about any prescription and over-the-counter medicines, vitamins, or herbal supplements you take.

What are the possible side effects of Repatha®?

Repatha® can cause serious side effects including, serious allergic reactions. Stop taking Repatha® and call your healthcare provider or seek emergency help right away if you have any of these symptoms: trouble breathing or swallowing, raised bumps (hives), rash or itching, swelling of the face, lips, tongue, throat or arms.

The most common side effects of Repatha® include: runny nose, sore throat, symptoms of the common cold, flu or flu-like symptoms, back pain, high blood sugar levels (diabetes), and redness, pain, or bruising at the injection site.

Tell your healthcare provider if you have any side effect that bothers you or that does not go away.

These are not all the possible side effects of Repatha®. Ask your healthcare provider or pharmacist for more information. Call your healthcare provider for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Please see full Prescribing Information.